Skip to content
Allegro Ophthalmics - From Theory to Therapy
  • About
    • Company
    • Management
    • Board of Directors
    • Scientific Advisors
  • Science
  • Pipeline
    • Pipeline
    • Risuteganib
    • ALG-1007
    • Clinical Trials
  • Therapeutic Areas
    • DME
    • Dry AMD
    • Dry Eye Disease
  • News
    • Press Releases
    • Features
    • Events

Modern Retina – The role of oxidative stress in DME

Posted on June 5, 2018 | by Allegro Ophthalmics, LLC

David S. Boyer, MD: The role of oxidative stress in DME
http://www.modernretina.com/dme/role-oxidative-stress-dme

Posted in Uncategorized
Allegro Ophthalmics - From Theory to Therapy

Setting the pace in ocular care
Read More >

Allegro Ophthalmics LLC
31473 Rancho Viejo Road, Suite 204
San Juan Capistrano, CA 92675, USA
Phone: +1 949.940.8130
Email: info@allegroeye.com

RECENT NEWS

Allegro Ophthalmics to Present the Results of Its Phase 2 Risuteganib Intermediate Dry Age-Related Macular Degeneration Study at the 19th EURETINA Congress and The Retina Society 2019 Annual Meeting
September 3, 2019

Allegro Ophthalmics to Present for the First Time the Results of Its Phase 2 Risuteganib Intermediate Dry Age-Related Macular Degeneration Study at the ASRS Annual Meeting 2019
July 24, 2019

Allegro Ophthalmics Announces Positive Topline Vision Results of Phase 2 Study Evaluating Risuteganib in Patients with Intermediate Dry Age-Related Macular Degeneration
June 4, 2019

  • About
  • Science
  • Pipeline
  • Therapeutic Areas
  • News
  • Careers
  • Contact Us
© 2019 Allegro Ophthalmics, LLC. All rights reserved. | Privacy Policy | Terms of Use